Viewing Study NCT04032093


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2026-01-27 @ 3:51 PM
Study NCT ID: NCT04032093
Status: COMPLETED
Last Update Posted: 2022-10-18
First Post: 2019-07-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-08-07
Start Date Type: ACTUAL
Primary Completion Date: 2021-09-30
Primary Completion Date Type: ACTUAL
Completion Date: 2021-09-30
Completion Date Type: ACTUAL
First Submit Date: 2019-07-22
First Submit QC Date: None
Study First Post Date: 2019-07-25
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-09-20
Results First Submit QC Date: None
Results First Post Date: 2022-10-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-09-20
Last Update Post Date: 2022-10-18
Last Update Post Date Type: ACTUAL